Belimumab modulates type I interferon signalling in the treatment of systemic lupus erythematosus
These results revealed a novel mechanism of belimumab action, advancing our understanding of the immune atlas in SLE patients before and after belimumab-targeting treatment.
Authors
- Tianrong Xun (ORCID: https://orcid.org/0000-0002-3786-0659)
- Qing Ding (ORCID: https://orcid.org/0000-0003-4842-0250)
- Liqian Mo (ORCID: https://orcid.org/0009-0000-1080-1870)
- Y Ye
- Xixiao Yang
Institutions
- Southern Medical University Shenzhen Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-06-21
- DOI
- https://doi.org/10.55563/clinexprheumatol/03t59o
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00